Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy
Author:
Affiliation:
1. Department of Hematology, Ebina General Hospital, Japan
2. Department of Histopathology, Ebina General Hospital, Japan
3. Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/62/17/62_0539-22/_pdf
Reference24 articles.
1. 1. Mashima K, Yano S, Yokoyama H, et al. Epstein-Barr virus-associated lymphoproliferative disorder with encephalitis following anti-thymocyte globulin for aplastic anemia resolved with rituximab therapy: a case report and literature review. Intern Med 56: 701-706, 2017.
2. 2. Shimizu H, Kobayashi N, Mihara M, et al. Successful treatment of Epstein-Barr virus-associated lymphoproliferative disorder with rituximab in a patient undergoing immunosuppressive therapy for aplastic anemia. Acta Haematol 136: 174-177, 2016.
3. 3. Tsukamoto S, Nagao Y, Yamazaki A, et al. Successful allogeneic stem cell transplantation for severe aplastic anemia after treatment of lymphoproliferative disorder caused by rabbit antithymocyte globulin. Intern Med 54: 3197-3200, 2015.
4. 4. Takahashi T, Maruyama Y, Saitoh M, et al. Fatal Epstein-Barr virus reactivation in an acquired aplastic anemia patient treated with rabbit antithymocyte globulin and cyclosporine A. Case Rep Hematol 2015: 926874, 2015.
5. 5. Hanaoka N, Murata S, Hosoi H, et al. B-cell-rich T-cell lymphoma associated with Epstein-Barr virus-reactivation and T-cell suppression following antithymocyte globulin therapy in a patient with severe aplastic anemia. Hematol Rep 7: 5906, 2015.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Infectious mononucleosis due to Epstein-Barr virus reactivation in an immunocompromised 60-year-old patient with COVID-19;Journal of Infection and Chemotherapy;2024-11
2. Antithymocyte-globulin/rituximab;Reactions Weekly;2023-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3